Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

The Occlutech implantable Atrial Flow Regulator (AFR) maintains an interatrial shunt with a predetermined diameter allowing for controlled blood flow from the left to the right atrium enabling the left atrium to decompress and lower left atrial pressure. This reduced left atrial pressure reduces heart failure symptoms and improves exercise tolerance.
News | Heart Failure
Occlutech's Atrial Flow Regulator for Heart Failure Receives FDA Breakthrough Device Designation

January, 27, 2021 — The U.S. Food and Drug Administration (FDA) has granted Occlutech a Breakthrough Device designation ...

Home January 27, 2021
Home
The Pedra Blood Perfusion Index tracks real-time changes in foot tissue perfusion attendant with balloon inflation and deflation during an angioplasty procedure.
News | Peripheral Artery Disease (PAD)
Pedra Tissue Perfusion System Receives FDA Breakthrough Device Designation

January 26, 2021 — Pedra Technology, a privately held company, announced today that the U.S. Food and Drug ...

Home January 26, 2021
Home
FDA Clears Boston Scientific Synergy Megatron Drug-eluting Stent for Proximal, Fibrotic and Calcified Lesions
News | Stents Drug Eluting
FDA Clears Boston Scientific Synergy Megatron Drug-eluting Stent for Proximal, Fibrotic and Calcified Lesions

January 26, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific's Synergy Megatron Drug ...

Home January 26, 2021
Home
An example of 3-D computer aided design (CAD) software from Materialise being used at Henry Ford Hospital to evaluate left ventricular outflow tract (LVOT) obstruction from a Sapian TAVR valve virtually implanted in the mitral valve position. Henry Ford uses both 3-D printing and CAD to plan and guide complex structural heart procedures. 
Feature | Medical 3-D Printing | By Dave Fornell, Editor
3-D Printing and Computer Aided Design Aids Structural Heart Interventions

With increasing complexity of interventional structural heart disease and congenital heart disease interventions, 3-D ...

Home January 24, 2021
Home
A new CMS national coverage determination for reimbursement for MitraClip significantly expand access to transcatheter mitral valve repair procedures for secondary mitral regurgitation.
News | Heart Valve Technology
Medicare Expands Coverage for MitraClip in Heart Failure Patients

January 20, 2021 — The U.S. Centers for Medicare and Medicaid Services (CMS) revised its National Coverage Determination ...

Home January 20, 2021
Home
More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell. Interventional X-ray market.
Feature | Angiography | By Bhvita Jani
Interventional X-ray Equipment Markets Plummeted in 2020 Due to COVID

January 19, 2021 – With the postponement of non-essential elective surgeries and medical procedures in 2020 to conserve ...

Home January 19, 2021
Home
Medtronic Evolut TAVR Cleared in Canada for Both Bicuspid Valves in Intermediate or Greater Risk and for All Low Risk Patients for TAVR
News | Structural Heart
Canada Clears Medtronic Evolut TAVR for Both Bicuspid Valves and for All Low Risk Patients

January 11, 2021 — Medtronic has received a new expanded indication from Health Canada for its Evolut Transcatheter ...

Home January 11, 2021
Home
The FDA has granted 510(k) clearance for the Inari Medical Inc. FlowTriever system for the treatment of clot in transit (CIT) in the right atrium. FlowTriever is the first thrombectomy system not requiring a cardiopulmonary bypass circuit to be FDA cleared for blood clots in the right atrium. 
News | Thrombectomy Devices
FDA Clears Inari Medical FlowTriever System for Treatment of Right Atrial Clot in Transit

January 8, 2021 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Inari Medical Inc ...

Home January 08, 2021
Home
The U.S. Food and Drug Administration (FDA) has granted the designation of breakthrough device to P+F Products + Features GmbH TricValve Transcatheter Bicval Valves System. The system uses two self-expanding valves in the vena cava for the treatment of patients with hemodynamically relevant tricuspid insufficiency without the need to touch the native tricuspid valve. #TTVR
News | Structural Heart
FDA Grants Break Through Device Designation for TricValve Transcatheter Bicaval Valves System

January 6, 2021 — The U.S. Food and Drug Administration (FDA) has granted the designation of breakthrough device to P+F ...

Home January 06, 2021
Home
First Patient Treated With Harpoon Transcatheter Mitral Valve Repair Device in U.S. Trial. #TMVR
News | Structural Heart
First Patient Treated With Harpoon Transcatheter Mitral Valve Repair Device in U.S. Trial 

December 29, 2020 — Edwards Lifesciences announced Dec. 21 that the first patient was treated in the RESTORE clinical ...

Home December 29, 2020
Home
Health Canada has approved the expanded use of the Edwards Lifesciences Sapien 3 and Sapien 3 Ultra transcatheter aortic valve replacement (TAVR) heart valves for the transfemoral treatment of patients diagnosed with severe symptomatic aortic stenosis who are at low risk for open-heart surgery. #TAVR #TAVI
News | Structural Heart
Edwards Sapien 3 TAVR Valve Receives Expanded Approval in Canada

December 29, 2020 — Health Canada has approved the expanded use of the Edwards Lifesciences Sapien 3 and Sapien 3 Ultra ...

Home December 29, 2020
Home
COVID-19 related topics by far out-paced all other topics in cardiology in 2020 on the DAIC website. Several stories topped the list related to the cardiovascular issues with hydroxychloroquine being used as a treatment for the virus. Top new device technologies in 2020 included European approval of the Abbott Tendyne transcatheter mitral valve, FDA approval of Medtronic's new Micra AV pill-sized pacemaker, and FDA clearance of the first drug-eluting stent with short-duration dual-antiplatelet therapy.
Feature | Dave Fornell, Editor
Top 25 Stories in Cardiology in 2020

Here are the top 25 best performing articles on the Diagnostic and Interventional Cardiology (DAIC) website from 2020 ...

Home December 28, 2020
Home
This year's top videos are dominated by COVID-19's impact on cardiology and many of the videos from a series produced this year on Tuft Medical Center's cardiology program. Top DAIC cardiology videos from 2020 #TuftsmedicalCenter #Tufts #COVID19
Feature | Dave Fornell, Editor
Top 25 Cardiology Videos on DAIC in 2020

Here are the top performing 25 videos on the DAIC website in 2020. The picks are based on Google Analytics of the DAIC ...

Home December 23, 2020
Home
Demonstrations videos of new technologoies are among the most popular video content on the DAIC website each year. Included this year are videos showing how it install a subcutaneous ICD, CT photo-realistic rendering, How to implants the Micra leadless pacemaker and many others.
Feature | Dave Fornell, Editor
Video Demonstrations of How Cardiovascular Technology Works

December 23, 2020 — Demonstrations of new technologies and explanations of how they work are among the most popular ...

Home December 23, 2020
Home
Thrombus formation in the aortic arch in a 46-year-old COVID patients in the ICU. Three trials are underway to find which anticoagulant strategy is best to treat moderate and critically ill patients where COVID-causes venous thrombo-embolism (VTE) is a major cause of complications. Image courtesy of Margarita Revzin et al.
Feature | Coronavirus (COVID-19)
NIH Pauses Anticoagulant Trial For Critically Ill COVID-19 Patients

December 23, 2020 — Three clinical trial platforms working together to test the effects of full doses of anticoagulants ...

Home December 23, 2020
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now